We are planning our annual conference as a face-to-face event under the 2G rule or the legal regulations applicable in 2023.
The scientific focus of the conference is on the therapy of rare diseases. While we have uncovered nearly 7,000 disease-causing genes, and there are fantastic therapeutic advances in some diseases, such as spinal muscular atrophy, our contribution to the development of new therapies based on genetic knowledge is needed more than ever.